Invivyd Inc/$IVVD
IVVD rises after announcing upsizing of its Phase 3 DECLARATION trial to boost statistical power and unveiling a new measles antibody candidate.
3 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Invivyd Inc
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Ticker
$IVVD
Sector
Primary listing
Employees
122
Headquarters
Website
Invivyd Inc Metrics
BasicAdvanced
$382M
-
-$0.30
0.61
-
Price and volume
Market cap
$382M
Beta
0.61
52-week high
$3.07
52-week low
$0.46
Average daily volume
2.7M
Financial strength
Current ratio
7.244
Quick ratio
7.063
Long term debt to equity
0.489
Total debt to equity
1.033
Profitability
EBITDA (TTM)
-54.805
Gross margin (TTM)
92.99%
Net profit margin (TTM)
-98.25%
Operating margin (TTM)
-103.99%
Revenue per employee (TTM)
$440,000
Management effectiveness
Return on assets (TTM)
-17.09%
Return on equity (TTM)
-33.96%
Valuation
Price to revenue (TTM)
4.352
Price to book
1.58
Price to tangible book (TTM)
1.58
Price to free cash flow (TTM)
-3.988
Free cash flow yield (TTM)
-25.07%
Free cash flow per share (TTM)
-0.338
Growth
Revenue change (TTM)
110.47%
Earnings per share change (TTM)
-78.74%
3-year earnings per share growth (CAGR)
-48.48%
Invivyd Inc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Invivyd Inc stock?
Invivyd Inc (IVVD) has a market cap of $382M as of April 09, 2026.
What is the P/E ratio for Invivyd Inc stock?
The price to earnings (P/E) ratio for Invivyd Inc (IVVD) stock is 0 as of April 09, 2026.
Does Invivyd Inc stock pay dividends?
No, Invivyd Inc (IVVD) stock does not pay dividends to its shareholders as of April 09, 2026.
When is the next Invivyd Inc dividend payment date?
Invivyd Inc (IVVD) stock does not pay dividends to its shareholders.
What is the beta indicator for Invivyd Inc?
Invivyd Inc (IVVD) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.